QUOTED. Sept. 3, 2018. Giulio Cerroni.
Executive Summary
Brain health imaging company IXICO says a new strategy of partnering with smaller biotech companies, whilst still not forgetting big pharma, has helped drive growth for the business in 2018. See what company CEO Giulio Cerroni said about it here.
"Historically we worked a lot with the big pharma companies which we continue to do, but we’ve also started to work with more biotech companies. This is part of our drive to innovate and explore new approaches. As smaller companies, they usually don’t have some of the internal resources the big companies have, so that’s where a small company like us can really benefit business-wise." – Giulio Cerroni, CEO, IXICO
- Find out more: IXICO’s New Biotech Contracts Help Drive Growth
Click here for a free trial of Medtech Insight